Form 4: Madrigal Director Sells Shares for Tax Obligations

Madrigal Pharmaceuticals Director Rebecca Taub sold 647 shares of common stock at $492.42 per share to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Rebecca Taub, a Director at Madrigal Pharmaceuticals, Inc. (MDGL), reported a sale of common stock.
• The transaction occurred on January 26, 2026.
• A total of 647 shares of common stock were sold at a price of $492.42 per share.
• This sale was automatic and non-discretionary, executed by the Issuer on behalf of the Reporting Person to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following this transaction, Rebecca Taub directly beneficially owns 452,704 shares of common stock.
• Additionally, 655,540 shares are indirectly beneficially owned through SQN LLC, where the Reporting Person and her spouse are managing members. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary sale of shares by a director to cover tax withholding obligations, which is a neutral event with no positive or negative implications for the company's operational or financial performance.

Industry Context

This Form 4 filing is a standard regulatory disclosure for insider transactions and does not provide information directly related to broader industry trends or competitive landscape. It reflects a routine compensation-related event for a director in the pharmaceutical sector.

Related Party Transactions

• Rebecca Taub, the reporting person, and her spouse are managing members of SQN LLC, which indirectly beneficially owns 655,540 shares of Madrigal Pharmaceuticals common stock. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.

Key Dates

Recommendation

The Form 4 filing details a routine, automatic sale of shares by a director to cover tax withholding obligations upon the vesting of restricted stock units. This is a non-discretionary transaction and does not reflect a change in the director's investment sentiment or the company's fundamentals, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

Madrigal Pharmaceuticals, MDGL, Form 4, Insider Trading, Stock Sale, Director, Rebecca Taub, Tax Withholding, Restricted Stock Units, Equity Compensation